Cosmo Pharmaceuticals N.V. (FRA:C43)

Germany flag Germany · Delayed Price · Currency is EUR
66.00
-1.50 (-2.22%)
At close: Sep 30, 2025
-2.22%
Market Cap1.10B
Revenue (ttm)182.27M
Net Income (ttm)59.99M
Shares Outn/a
EPS (ttm)3.67
PE Ratio18.35
Forward PE31.45
Dividend2.05 (3.08%)
Ex-Dividend DateJun 4, 2025
Volumen/a
Average Volume329
Open67.50
Previous Close67.50
Day's Range66.00 - 67.50
52-Week Range47.80 - 81.00
Betan/a
RSI46.85
Earnings DateOct 23, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 322
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.